Interventions for the management of oral submucous fibrosis

Z Fedorowicz; Shih-Yen E Chan; M Dorri; M Nasser; T Newton; L Shi

doi:10.1002/14651858.CD007156.pub2

Interventions for the management of oral submucous fibrosis

Z Fedorowicz
, Shih-Yen E Chan
, M Dorri
, M Nasser
, T Newton
, L Shi

Institute for Quality and Efficiency in Health care, Köln, Germany

Research output: Contribution to journal › Article › peer-review

Abstract

Oral submucous fibrosis (OSF) is a chronic disease of the oral cavity which is more commonly found in patients in the Asian subcontinent and the Far East. It is characterised by the progressive build up of constricting bands of collagen in the cheeks and adjacent structures of the mouth which can severely restrict mouth opening and tongue movement and cause problems with speech and swallowing.

Original language	English
Journal	Cochrane Database Syst Rev
Volume	4
Early online date	23 Apr 2008
DOIs	https://doi.org/10.1002/14651858.CD007156.pub2 https://doi.org/10.1002/14651858.cd007156
Publication status	Published - 23 Apr 2008
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Adult
Carotenoids
Hot Temperature
Humans
Oral Submucous Fibrosis
Pentoxifylline
Steroids
Vasodilator Agents

Access to Document

Cite this

@article{d8ed92bf174e4c7386f8edd036c6106e,

title = "Interventions for the management of oral submucous fibrosis",

abstract = "Oral submucous fibrosis (OSF) is a chronic disease of the oral cavity which is more commonly found in patients in the Asian subcontinent and the Far East. It is characterised by the progressive build up of constricting bands of collagen in the cheeks and adjacent structures of the mouth which can severely restrict mouth opening and tongue movement and cause problems with speech and swallowing.",

keywords = "Adult, Carotenoids, Hot Temperature, Humans, Oral Submucous Fibrosis, Pentoxifylline, Steroids, Vasodilator Agents",

author = "Z Fedorowicz and Chan, \{Shih-Yen E\} and M Dorri and M Nasser and T Newton and L Shi",

year = "2008",

month = apr,

day = "23",

doi = "10.1002/14651858.CD007156.pub2",

language = "English",

volume = "4",

journal = "Cochrane Database Syst Rev",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Interventions for the management of oral submucous fibrosis

AU - Fedorowicz, Z

AU - Chan, Shih-Yen E

AU - Dorri, M

AU - Nasser, M

AU - Newton, T

AU - Shi, L

PY - 2008/4/23

Y1 - 2008/4/23

N2 - Oral submucous fibrosis (OSF) is a chronic disease of the oral cavity which is more commonly found in patients in the Asian subcontinent and the Far East. It is characterised by the progressive build up of constricting bands of collagen in the cheeks and adjacent structures of the mouth which can severely restrict mouth opening and tongue movement and cause problems with speech and swallowing.

AB - Oral submucous fibrosis (OSF) is a chronic disease of the oral cavity which is more commonly found in patients in the Asian subcontinent and the Far East. It is characterised by the progressive build up of constricting bands of collagen in the cheeks and adjacent structures of the mouth which can severely restrict mouth opening and tongue movement and cause problems with speech and swallowing.

KW - Adult

KW - Carotenoids

KW - Hot Temperature

KW - Humans

KW - Oral Submucous Fibrosis

KW - Pentoxifylline

KW - Steroids

KW - Vasodilator Agents

U2 - 10.1002/14651858.CD007156.pub2

DO - 10.1002/14651858.CD007156.pub2

M3 - Article

SN - 1469-493X

VL - 4

JO - Cochrane Database Syst Rev

JF - Cochrane Database Syst Rev

ER -

Interventions for the management of oral submucous fibrosis

Abstract

UN SDGs

Keywords

Access to Document

Fingerprint

Cite this